| Article | Date | Source |
|---|
| Acorda Therapeutics (ACOR) Joins NY BioHud Valley as Founding Member | -- | Pharmaceutical - Moreover |
| Acorda Therapeutics Joins as Founding Member | -- | Biotechnology - Moreover |
| Acorda Therapeutics to FDA: What Deadlines? | May 17, 2012 | BioSpace |
| Acorda Therapeutics Presents AMPYRA® Long-Term Safety and Efficacy Data at 64th American Academy of Neurology Annual Meeting | April 25, 2012 | FDA News - Business Wire |
| Acorda Eyes Additions to Neurodegenerative Disease Drug Pipeline | April 18, 2012 | Inside Industry - Gen |
| Five Questions: Acorda CEO Ron Cohen on the Future of Neurology R&D | April 17, 2012 | Xconomy Life Sciences |
| Acorda Therapeutics to Provide Pipeline Update at Upcoming R&D Day | April 10, 2012 | Biotech News - Business Wire |
| Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampyra® (Dalfampridine) of Walking Problems in Patients with Multiple Sclerosis | April 02, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the Cowen & Company 32nd Annual Health Care Conference | February 27, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at 2012 RBC Capital Markets' Global Healthcare Conference | February 22, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at Citi 2012 Global Health Care Conference | February 21, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics Buying Morrisville-based Neuronex Inc. for Up to $35 Million | February 17, 2012 | BioSpace - Breaking News |
| Acorda Therapeutics Buying Morrisville-based for Up to $35 Million | February 17, 2012 | BioSpace - Breaking News |
| Acorda buying Morrisville-based Neuronex | February 17, 2012 | Health News - BizJournals.com |
| Acorda 4Q profit climbs; company buying Neuronex | February 16, 2012 | Health News - CNBC |
| Acorda Therapeutics Names Jane Wasman as Chief, Strategic Development | February 13, 2012 | Biotech News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 | February 09, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference | February 09, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES?? | February 07, 2012 | BioSpace - Breaking News |
| Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference | February 07, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke | February 03, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics Makes a Move: Down... | January 24, 2012 | Biotechnology - Moreover |
| Biotechnology firm Acorda Therapeutics ([[ACOR +4%) gains after saying that due to successful marketing efforts, it expects sales of Ampyra to rise to $255M - $275M in 2012, up from $210M last year. | January 09, 2012 | Biotechnology - Moreover |
| Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference | January 09, 2012 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Preclinical Data on GGF2 in Heart Failure Presented at American Heart Association Scientific Sessions 2011 | November 16, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Reports Third Quarter 2011 Financial Results | November 04, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Discuss Third Quarter 2011 Financial Results on November 4, 2011 | October 27, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Data on AMPYRA® Presented at 5th Joint Triennial Congress of ECTRIMS and ACTRIMS | October 21, 2011 | Biotech News - Business Wire |
| Acorda Therapeutics's Shares... | October 01, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer | September 15, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the UBS Global Life Sciences Conference | September 12, 2011 | Pharma News - Business Wire |
| Acorda says court voids patent on Zanaflex | September 07, 2011 | Health News - CNBC |
| Acorda Therapeutics Statement on ZANAFLEX CAPSULES® Patent Litigation | September 07, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the Morgan Stanley Global Healthcare Conference | September 06, 2011 | Pharma News - Business Wire |
| Acorda CEO Cohen throws his weight behind new biotech trailblazer | August 15, 2011 | FierceBiotech |
| Acorda Therapeutics Joins as Founding Member
| August 15, 2011 | BioSpace - Breaking News |
| Acorda Therapeutics Joins NY BioHud Valley as Founding Member | August 15, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Allowance of Second U.S. Patent Application for AMPYRA(R) Covering Methods of Use for Improving Walking in Multiple Sclerosis
| August 10, 2011 | BioSpace - Breaking News |
| Acorda Therapeutics Announces Allowance of Second U.S. Patent Application for AMPYRA® Covering Methods of Use for Improving Walking in Multiple Sclerosis | August 10, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Chief Scientific Officer Andrew R. Blight Recognized among PharmaVOICE’s 100 Most Inspiring People | August 02, 2011 | FDA News - Business Wire |
| Acorda Therapeutics (ACOR) Reports Second Quarter | August 01, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics narrows 2Q loss | August 01, 2011 | Health News - CNBC |
| Acorda Therapeutics Reports Second Quarter 2011 Financial Results | August 01, 2011 | Pharma News - Business Wire |
| Acorda to relocate to Ardsley Park - 138,000 s/f | July 26, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics to Host Conference Call to Discuss Second Quarter 2011 Financial Results on August 1, 2011 | July 25, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Pay up to $35 Million To Medtronic, Inc. in Licensing Deal | July 01, 2011 | BioSpace - Breaking News |
| Acorda Therapeutics Pays $35 Million for Medtronic, Inc. Drug, Fills Out Mid-Stage Neurology Pipeline
| July 01, 2011 | BioSpace |
| Acorda snags Ph2 neurological trauma program in $35M deal | July 01, 2011 | FierceBiotech |
| Acorda Licenses Phase II-ready Brain and Spinal Cord Injury Candidate from Medtronic | July 01, 2011 | Inside Industry - Gen |
| Acorda Therapeutics Licenses Rights to Investigational Treatment for Spinal Cord Injury and Traumatic Brain Injury | July 01, 2011 | Pharma News - Business Wire |
| Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline | July 01, 2011 | Xconomy Life Sciences |
| Acorda Therapeutics Wins Telly Awards in Documentary and Public Relations Categories | June 30, 2011 | Biotech News - Business Wire |
| Acorda to move corporate headquarters to Ardsley Park life science campus | June 27, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics to Relocate Corporate Headquarters to Ardsley Park Life Science Campus; Site Acquired and Now Managed by BioMed Realty Trust | June 27, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics (ACOR) Wins Two 20 | June 25, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics Wins Two 2011 Stevie Awards at the 9th Annual American Business Awards | June 24, 2011 | Pharma News - Business Wire |
| Analyst raises Acorda target as Ampyra sales grow | June 13, 2011 | Health News - CNBC |
| Acorda Therapeutics (ACOR): Upgraded by Piper... | May 23, 2011 | Biotechnology - Moreover |
| Acorda Stock Soars on European Surprise | May 20, 2011 | Xconomy Life Sciences |
| Acorda Therapeutics Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA(R) in Europe | May 20, 2011 | BioSpace - Breaking News |
| Acorda MS drug receives conditional endorsement | May 20, 2011 | Health News - CNBC |
| Acorda Therapeutics Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA® in Europe | May 20, 2011 | Pharma News - Business Wire |
| Relatively Low Operating Margin Detected in Shares of Acorda Therapeutics in the Biotechnology Industry (ACOR, CPHD, BMRN, SSRX, RGEN) | May 12, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics Recognized as One of the Best Places to Work in New York State | May 09, 2011 | Pharma News - Business Wire |
| Acorda 1Q loss narrows on Ampyra sales | May 05, 2011 | Health News - CNBC |
| Acorda Therapeutics Reports First Quarter 2011 Financial Results | May 05, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Report First Quarter 2011 Financial Results on May 5, 2011 | April 28, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Ranked Fifth in The Scientist Best Places to Work in Industry 2011 Survey | April 28, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Changes to Board of Directors | April 20, 2011 | Pharma News - Business Wire |
| Acorda Issued Patent on MS Drug Following Days of Speculation | April 19, 2011 | Xconomy Life Sciences |
| Acorda Therapeutics Announces Allowance of U.S. Patent Application for AMPYRA® (dalfampridine) Covering Methods of Use for Improving Walking in Multiple Sclerosis | April 19, 2011 | Pharma News - Business Wire |
| Acorda shares soar on possible patent extension of MS drug | April 14, 2011 | Health News - CNBC |
| Acorda Stock Halted as Shares Skyrocket on Patent Speculation | April 14, 2011 | Xconomy Life Sciences |
| Acorda Therapeutics Presents New AMPYRA® (dalfampridine) Data Analyses on Walking Improvement in Multiple Sclerosis at AAN Annual Meeting | April 11, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics Executive VP and General Counsel Jane Wasman to Present at New York Biotechnology Association 20th Annual Meeting | April 05, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics (ACOR) to Present at the Cowen and Company | March 01, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics to Present at the Cowen & Company 31st Annual Health Care Conference | February 28, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics (ACOR) to Present at the Citi 20 | February 23, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics to Present at the Citi 2011 Global Health Care Conference | February 22, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics (ACOR) Reports Fourth Quarter and Full Year 20 | February 18, 2011 | Biotechnology - Moreover |
| Acorda reports 4Q profit on Ampyra sales | February 17, 2011 | Health News - CNBC |
| Acorda Therapeutics Reports Fourth Quarter and Full Year 2010 Financial Results | February 17, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference | February 15, 2011 | Biotech News - Business Wire |
| Acorda Therapeutics (ACOR) to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on February 17, 20 | February 10, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on February 17, 2011 | February 10, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics (ACOR) to Present at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference | February 07, 2011 | Biotechnology - Moreover |
| Acorda Therapeutics to Present at the 13th Annual BIO CEO & Investor Conference | February 07, 2011 | Pharma News - Business Wire |
| Summary Box: Acorda stock falls after drug spurned | January 21, 2011 | Health News - CNBC |
| Acorda stock falls on European drug rejection | January 21, 2011 | Health News - CNBC |
| Ahead of the Bell: Acorda Therapeutics skids | January 21, 2011 | Health News - CNBC |
| Acorda's Ampyra sales total $141.4 million in 2010 | January 10, 2011 | Health News - CNBC |
| Acorda Therapeutics To Provide Business Update Today at J.P. Morgan Healthcare Conference | January 10, 2011 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference | January 04, 2011 | Pharma News - Business Wire |
| Acorda's Ampyra Sustains High Levels of Interest Seven Months After Launch With Favorable Future Share Projections | December 13, 2010 | Biotech News - PR Newswire |
| Acorda Initiates Phase 1 GGF2 Clinical Trial | December 10, 2010 | Pharmaceutical - Moreover |
| Acorda Therapeutics Announces Initiation of Phase 1 GGF2 Clinical Trial in Patients with Heart Failure | December 09, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the 2010 Deutsche Bank BioFEST Conference | December 07, 2010 | Pharma News - Business Wire |
| Equity Research on Amgen Inc. and Acorda Therapeutics Inc. - Sneak Peek in the Biotech Industry | December 02, 2010 | Biotechnology - Moreover |
| Acorda Therapeutics to Present at the J.P. Morgan SMid Cap Conference | November 24, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the 22nd Annual Piper Jaffray Health Care Conference | November 23, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Release: Additional Phase 3 Clinical Trial Data Published in <i>Annals of Neurology</i> Showing Dalfampridine Extended Release Tablets Improved Walking Ability in People with Multiple Sclerosis | November 17, 2010 | BioSpace - Breaking News |
| Acorda Therapeutics to Present at the Lazard Capital Markets 7th Annual Healthcare Conference | November 09, 2010 | Pharma News - Business Wire |
| Shares of Acorda Therapeutics Under Pressure, Down 0.5% (ACOR) | November 03, 2010 | Biotechnology - Moreover |
| Acorda swings to 3Q profit due to MS drug | November 01, 2010 | Health News - CNBC |
| Acorda Therapeutics Posts Profit On MS Walking Drug | November 01, 2010 | BioSpace - Breaking News |
| Acorda Therapeutics Reports Third Quarter 2010 Financial Results | November 01, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Report Third Quarter 2010 Financial Results on November 1, 2010 | October 25, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the 17th Annual NewsMakers in the Biotech Industry Conference | October 18, 2010 | Pharma News - PharmiWeb |
| Acorda Therapeutics Announces Data on AMPYRA® (dalfampridine) Presented at 26th Congress of European Committee for Treatment and Research in Multiple Sclerosis | October 15, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics: Stock on the Move Lower, Down 3.6% (ACOR) | October 12, 2010 | Biotechnology - Moreover |
| Acorda Therapeutics to Present at the Fifth Annual JMP Securities Healthcare Conference | September 20, 2010 | Pharma News - Business Wire |
| Acorda's Ampyra Continues to Gain Traction and Both Breadth and Depth of Adoption are Expected to Increase Over the Next Six Months | September 09, 2010 | Pharma News - PR Newswire |
| Acorda Shares Up As MS Drug Ampyra Shows Early Strength In 2Q | August 03, 2010 | Health News - Fox Business |
| Acorda 2Q loss narrows on Ampyra sales | August 03, 2010 | Health News - CNBC |
| Acorda Therapeutics MS Walking Drug Sales Shine; Loss Narrows | August 03, 2010 | BioSpace |
| Acorda Therapeutics Reports Second Quarter 2010 Financial Results | August 03, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Report Second Quarter 2010 Financial Results on August 3, 2010 | July 27, 2010 | Pharma News - Business Wire |
| Acorda gets $1M heart failure therapy grant | July 20, 2010 | Health News - CNBC |
| Biogen 2Q profit doubles without Acorda payment | July 20, 2010 | Health News - CNBC |
| Acorda Therapeutics Announces Receipt of NIH Grant for Development of GGF2 in Heart Failure | July 20, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety | July 07, 2010 | Pharma News - Business Wire |
| NYBA recognizes Acorda Therapeutics President with The Cures Start Here Business Leader of the Year Award | June 08, 2010 | Biotechnology - Moreover |
| Acorda Therapeutics President and CEO Ron Cohen Receives New York Biotechnology Association Business Leader of the Year Award | June 08, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Present Data at Joint Consortium of Multiple Sclerosis Centers and Americas Committee on Treatment and Research in Multiple Sclerosis Annual Meetings | June 02, 2010 | Pharma News - Business Wire |
| Acorda's Ampyra is Seen as a Welcomed Addition to Existing Disease-Modifying Agents for the Improvement of Walking Speed in Multiple Sclerosis Patients, According to U.S. Neurologists, Even as Product Access Proves Frustrating | June 02, 2010 | Medical Pharma - PR Newswire |
| Acorda Therapeutics (ACOR) Chief Scientific Officer Andrew R. Blight to Deliver Keynote Lecture at American Spinal Injury Association 36th Annual Scientific Meeting | May 25, 2010 | Biotechnology - Moreover |
| Acorda Therapeutics Chief Scientific Officer Andrew R. Blight to Deliver Keynote Lecture at American Spinal Injury Association 36th Annual Scientific Meeting | May 25, 2010 | Pharma News - Business Wire |
| New York Biotechnology Association to Honor Acorda Therapeutics (ACOR) CEO and VWR International, Inc. with Annual Leadership Awards | May 19, 2010 | Biotechnology - Moreover |
| New York Biotechnology Association to Honor Acorda Therapeutics CEO and VWR International with Annual Leadership Awards | May 19, 2010 | FDA News - Business Wire |
| Acorda Therapeutics Recognized by National Organization for Rare Disorders for Contribution to Treatment of Multiple Sclerosis | May 18, 2010 | FDA News - Business Wire |
| Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2010 Health Care Conference | May 05, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Chief Executive Officer Ron Cohen Elected Chairman of BIO Emerging Companies Section | May 04, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Reports First Quarter 2010 Financial Results | April 30, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Report First Quarter 2010 Financial Results on April 30, 2010 | April 23, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Investigational New Drug Application Accepted for GGF2 for Treatment of Heart Failure | April 20, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Data on AMPYRA™ (dalfampridine) Presented at American Academy of Neurology Meeting | April 13, 2010 | Pharma News - Business Wire |
| Acorda deals MS med direct to patients | March 29, 2010 | FiercePharma |
| Citi Starts Acorda Therapeutics (ACOR) at Hold, $39 Price Target | March 29, 2010 | Biotechnology - Moreover |
| Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA(TM) (dalfampridine) | March 22, 2010 | BioSpace - Breaking News |
| Acorda Therapeutics submits applications to extend patent protection for AMPYRA to USPTO | March 22, 2010 | Pharmaceutical - Moreover |
| Acorda applies to extend Ampyra patent protection | March 22, 2010 | Health News - CNBC |
| Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA™ (dalfampridine) | March 22, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Present at the Cowen and Company 30th Annual Health Care Conference | March 02, 2010 | Biotech News - Business Wire |
| Acorda Therapeutics Announces Availability of AMPYRA™ (dalfampridine) | March 01, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Participate in Panel at the RBC Capital Markets Healthcare Conference | February 25, 2010 | Pharma News - Business Wire |
| Ahead of the Bell: Acorda Therapeutics | February 24, 2010 | Health News - CNBC |
| Acorda Therapeutics appoints new senior vice president of medical affairs | February 23, 2010 | Biotechnology - Moreover |
| Acorda Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results | February 23, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs | February 22, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on February 23, 2010 | February 17, 2010 | Pharma News - Business Wire |
| Buyers Accumulate Shares of Acorda Therapeutics, Up 1.5% (ACOR) | February 11, 2010 | Biotechnology - Moreover |
| Acorda's Lucky Number 13 | February 03, 2010 | Health News - CNBC |
| Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference | February 03, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA™ (dalfampridine) | February 03, 2010 | Pharma News - Business Wire |
| Resumen: Regis Technologies pasa inspección pre-aprobación de la FDA para AmpyraTM de Acorda Therapeutics, fármaco aprobado para el tratamiento de la esclerosis múltiple | January 29, 2010 | FDA News - Business Wire |
| Regis Technologies Passes FDA Pre-Approval Inspection for Acorda ... | January 29, 2010 | Pharmaceutical - Moreover |
| Regis Technologies Passes FDA Pre-Approval Inspection for Acorda Therapeutics Approved Multiple Sclerosis Drug, Ampyra? | January 29, 2010 | Pharmaceutical - Moreover |
| Regis Technologies passe la « Pre-Approval Inspection » de la FDA pour Ampyra™ d'Acorda Therapeutics, médicament approuvé contre la sclérose en plaques | January 29, 2010 | FDA News - Business Wire |
| Regis Technologies Passes FDA Pre-Approval Inspection for Acorda Therapeutics' Approved... | January 28, 2010 | Pharmaceutical - Moreover |
| Samenvatting: Regis Technologies doorstaat pre-approval inspectie van FDA voor Ampyra™, het goedgekeurde medicijn tegen multiple sclerose van Acorda Therapeutics | January 28, 2010 | FDA News - Business Wire |
| Regis Technologies Passes FDA Pre-Approval Inspection for Acorda Therapeutics' Approved Multiple Sclerosis Drug, Ampyra„ | January 28, 2010 | Pharmaceutical - Moreover |
| Riassunto: Positiva l'ispezione pre-approvazione della FDA per Regis Technologies, che commercializzerà il farmaco di Acorda Therapeutics Ampyra™, approvato per la sclerosi multipla | January 28, 2010 | FDA News - Business Wire |
| Regis Technologies Passes FDA Pre-Approval Inspection for Acorda Therapeutics Approved Multiple Sclerosis Drug, Ampyra | January 28, 2010 | Pharmaceutical - Moreover |
| Regis Technologies Passes FDA Pre-Approval Inspection for Acorda Therapeutics’ Approved Multiple Sclerosis Drug, Ampyra™ | January 28, 2010 | FDA News - Business Wire |
| Acorda Therapeutics announces new executive appointment | January 26, 2010 | Biotechnology - Moreover |
| US FDA Approves Acorda Therapeutics MS Drug to Help with Walking | January 25, 2010 | BioSpace - Breaking News |
| US Approves Acorda Therapeutics MS Drug to Help with Walking | January 25, 2010 | BioSpace |
| Acorda Gains Approval for Ampyra | January 25, 2010 | Contract Pharma |
| Acorda Obtains FDA Nod for Oral Drug that Improves Walking in MS Patients | January 25, 2010 | GEN News Highlights |
| Acorda MS drug approval sparks buyout buzz | January 25, 2010 | FierceBiotech |
| Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development | January 25, 2010 | Pharma News - Business Wire |
| Acorda Therapeutics wins FDA approval for multiple sclerosis | January 25, 2010 | Biotechnology - Moreover |
| FDA approves Acorda's new MS drug | January 22, 2010 | FierceBiotech |
| FDA clears Acorda drug for multiple sclerosis | January 22, 2010 | Health News - CNBC |
| Acorda Therapeutics Announces FDA Approval of AMPYRA™ (dalfampridine) to Improve Walking in People with Multiple Sclerosis – Demonstrated by Increases in Walking Speed | January 22, 2010 | FDA News - Business Wire |
| BREAKING NEWS: FDA approves Acorda's new MS drug | January 22, 2010 | FierceBiotech |
| Acorda Therapeutics to Present at the 28th Annual JPMorgan Healthcare Conference | | Biotech News - Business Wire |
| Acorda Therapeutics to Present at the 2009 Deutsche Bank Biotech Boston Confab | | Pharma News - Business Wire |
